[1] Qu J, Liu C, Lian H,et al.Qingfeijianpi therapy for persistent allergic rhinitis[J].Medicine,2018,97(23):961-963. [2] Wang Y, Li C, Xu Y,et al.Sublingual immunotherapy decreases expression of interleukin-33 in children with allergic rhinitis[J].Indian J Pediatr,2018,26(6):56-58. [3] Vieira-Hernández A, Capriles-Hulett A, Sánchez-Borges M, et al. Intradermal immunotherapy with low-dose house dust mite allergens in patients with allergic rhinitis: A proof-of-concept study[J].Rev Alerg Mex,2018,65(1):41-51. [4] 宋薇薇,林小平,柴若楠. 变应性鼻炎屋尘螨皮下免疫治疗远期疗效评估[J].中华耳鼻咽喉头颈外科杂志,2015,50(8):632-635. [5] Masuyama K, Matsuoka T, Kamijo A.Current status of sublingual immunotherapy for allergic rhinitis in Japan[J].Allergol Int,2018,34(5):34-37. [6] 陈毛毛. 畅迪试剂脱敏治疗小儿变应性鼻炎的临床疗效及对嗜酸性粒细胞、嗜酸性粒细胞阳离子蛋白水平的影响[J].中国中西医结合儿科学,2017,9(3):252-255. [7] 刘碧霞,梁月娥,李玉云,等. 皮下注射脱敏治疗儿童变应性鼻炎的安全性及依从性观察[J].中国耳鼻咽喉颅底外科杂志,2015,21(3):245-247. [8] 任华丽,李健东,苗燕华,等. 义诊变应性鼻炎患者对标准化屋尘螨皮下注射脱敏治疗接受程度的调查[J].中华疾病控制杂志,2016,20(9):967-968.
2019, Vol. 36 
